Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing "off the shelf" allogeneic cell therapies for serious medical conditions, today announced that 36-month results from ...
Discusses Bezisterim's Mechanism of Action and Its Potential in Addressing Parkinson's Disease Pathology May 7, 2026 2:00 PM ...
Horizon Kinetics analyzes market structure biases and the long-term value of asset-light royalty companies and CLOs. Read the ...
Part A of LIGHTHOUSE Trial reinforce ATSN-201's favorable safety profile and durable structural and functional benefits in ...
India, May 8 -- Malaria remains one of the world's deadliest infectious diseases, despite being preventable and treatable.
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS ® ...
Six-month data from adult Cohort 4 show structural and functional improvements and a favorable safety profile; early safety data from pediatric ...
The Musk v. Altman trial is underway, and that means exhibits, or the evidence to be presented in court, are being revealed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results